Updated:
Indalo Therapeutics
Indalo Therapeutics is a preclinical-stage biotechnology company based in St. Louis, United States, founded in 2014. It has secured $11.8 million in total...
Overview
Indalo Therapeutics is a preclinical-stage biotechnology company based in St. Louis, United States, founded in 2014. It has secured $11.8 million in total funding.
General information
Firm type
Asset Manager
Location
Region
North America
Country
United States
City
St. Louis
Corporate office
St. Louis, MO, United States
Sector focus
Frequently asked questions
Who runs Indalo Therapeutics?
No named principals or leadership team members have been publicly identified for Indalo Therapeutics. The firm does not list management on a website or in any accessible publication as of mid-2026.
How much capital does Indalo Therapeutics manage?
Indalo Therapeutics does not disclose AUM or deployment figures. No regulatory filings or press reports provide a capital estimate.
What investment stages does Indalo Therapeutics target?
Indalo Therapeutics' investment focus has not been documented. It is unclear whether it makes direct investments, fund commitments, or operates as a therapeutic developer.
Where can I find more information about Indalo Therapeutics?
The firm's website is indalotherapeutics.com, but no substantive content was scraped from it as of 2026. It does not have a public LinkedIn profile or appear in major industry databases.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: